Literature DB >> 932559

An improved and simplified radioisotopic assay for the determination of free and esterified carnitine.

J D McGarry, D W Foster.   

Abstract

The radioisotopic assay for carnitine first described by Cederblad and Lindstedt (Clin. Chim. Acta. 37:235-543, 1972) and modified by Bohmer et al (Clin. Chim. Acta. 57:55-61, 1974) has been improved and simplified. As a result, the assay yields a linear response over a wide range of carnitine concentrations without the need for excessive amounts of labeled acetyl-CoA. In addition, it will measure very small quantities of carnitine even in the presence of excess acylcarnitine. The method allows rapid determination of free and esterified carnitine in small volumes of plasma (50 mul is sufficient) without the need for prior deproteinization of the samples.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932559

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  73 in total

1.  Emetine-induced myopathy and carnitine deficiency.

Authors:  T Kuntzer; H Reichmann; J Bogousslavsky; F Regli
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

2.  Subnormal carnitine levels and their correction in artificially fed patients from a neurological intensive care unit: a pilot study.

Authors:  J Schäfer; H Reichmann
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

3.  Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart.

Authors:  R Ferrari; E Pasini; E Condorelli; A Boraso; R Lisciani; A Marzo; O Visiou
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

4.  Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium.

Authors:  K A Yamada; D J Dobmeyer; E M Kanter; S G Priori; P B Corr
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

5.  Potential role of carnitine in patients with renal insufficiency.

Authors:  C Wanner; W H Hörl
Journal:  Klin Wochenschr       Date:  1986-07-01

6.  Mitochondrial very long-chain acyl-CoA dehydrogenase deficiency with a mild clinical course.

Authors:  B Merinero; C Pérez-Cerdá; M J Garcia; J Gangoiti; L M Font; M T Garcia Silva; C Vianey-Saban; M Duran; M Ugarte
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

7.  Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.

Authors:  A Marzo; E Arrigoni Martelli; R Urso; M Rocchetti; V Rizza; J G Kelly
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

8.  Glycine and L-carnitine therapy in 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  S L Rutledge; G T Berry; C A Stanley; J L van Hove; D Millington
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

9.  Effects of carnitine in ischemic and fatty acid supplemented swine hearts.

Authors:  A J Liedtke; S H Nellis
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

10.  Pharmacokinetics of oral acetyl-L-carnitine in renal impairment.

Authors:  J G Kelly; S Hunt; G D Doyle; M S Laher; M Carmody; A Marzo; E Arrigoni Martelli
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.